Clinical Trial Update: Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update indicates recruitment is ongoing to test whether atorvastatin can reduce inflammation after completion of tuberculosis treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: University of Cape Town | Conditions: Tuberculosis, Pulmonary | Phase 2, Phase 3 | Status: RECRUITING